Decreased Local Control Following Radiation Therapy Alone in Early-Stage Glottic Carcinoma with Anterior Commissure Extension

Strahlentherapie und Onkologie

Volumn 180, Issue 2, 2004, Pages 84-90

  Zouhair, Abderrahim ^a   Azria, David ^a   Coucke, Philippe ^a   Matzinger, Oscar ^a   Bron, Luc ^a   Moeckli, Raphael ^b   Do, Huu Phuoc ^b   Mirimanoff, René Olivier ^a   Ozsahin, Mahmut ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b University Institute of Applied Radiophysics   (Switzerland)

Author keywords

Anterior commissure; Glottic cancer; Local relapse; Radiotherapy; Surgery

Indexed keywords

ADULT; AGE; AGED; ANTERIOR COMMISSURE; CANCER CONTROL; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; DISEASE COURSE; FEMALE; FOLLOW UP; GLOTTIS; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX CARTILAGE; LARYNX TUMOR; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MORALITY; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION PROTECTION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEX RATIO; SQUAMOUS CELL CARCINOMA; SURVIVAL; SURVIVAL RATE; SWITZERLAND; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; THYROID CARTILAGE; TREATMENT FAILURE;

EID: 0842263696     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1164-y     Document Type: Conference Paper

References (71)

1. Allal AS, Miralbell R, Lehmann W, et al. Effect of arytenoids sparing during radiation therapy of early glottic carcinoma. Radiother Oncol 1997;43:63-5.
2. Aref A, Dworkin J, Devi S, et al. Objective evaluation of the quality of voice following radiation therapy for T1 glottic cancer. Radiother Oncol 1997;45:149-53.
3. Awwad S, Jarros E, Jomes J, et al. p53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys 1996;36:323-32.
4. Barton MB, Keane TJ, Gadalla T, et al. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992;23:137-43.
5. Benninger MS, Gillen J, Thieme P, et al. Factors associated with recurrence and voice quality following radiation therapy for T1-T2 glottic carcinoma. Laryngoscope 1994;104:294-8.
6. Bieri S, Bentzen SM, Huguenin P, et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 2003;179:390-5.
7. Bron L, Brossard E, Monnier PH, et al. Supracricoid partial Laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope 2000;110:627-34.
8. Bron LP, Soldati D, Zouhair A, et al. Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck 2002;23:823-8.
9. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328:159-63.
10. Chatani M, Matayoshi Y, Masaki N, et al. Radiation therapy for early glottic carcinoma (T1N0M0): the adverse effect of treatment interruption. Strahlenther Onkol 1997;173:502-6.
11. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
12. Davis RK. Endoscopic management of glottic laryngeal cancer. Otolaryngol Clin North Am 1997;30:79-86.
13. Dobaski Y, Sakamoto A, Sugimara H, et al. p53 overexpression in an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 1992;52:178-82.
14. Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences Local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-83.
15. Fletcher GH, Goepfert H. Larynx and pyriform sinus. In: Fletcher GH, ed. Textbook of radiotherapy, 3rd edn. Philadelphia: Lea & Febiger, 1980:330-63.
16. Foote LR, Grado GL, Buskirk SJ, et al. Radiation therapy for glottic cancer using 6-MV photons. Cancer 1996;77:381-6.
17. Foote RL, Olsen KD, Kunselman SJ, et al. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc 1992;67:629-36.
18. Fowler JF, Chappell R. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy. Eur J Cancer 1994;30A:719-21.
19. Fowler JF, Lindström M. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-67.
20. Franchin G, Minatel E, Gobitti C, et al. Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis. Int J Radiat Oncol Biol Phys 1998;40:541-8.
21. Frein DA, Mendenhall WM, Parsons JT, et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 1993;25:605-11.
22. Garden AS, Forster K, Wong PF, et al. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 2003;55:322-8.
23. Grégoire V, Hamoir M, Rosier JF, et al. Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiother Oncol 1999;53:1-13.
24. Greisen O, Carl J, Pederson M. A consecutive series of patients with laryngeal carcinoma treated by primary irradiation. Acta Oncol 1997;36:279-82.
25. Harrison LB, Solomon B, Miller S, et al. Prospective computer-assisted voice analysis for patients with early stage glottic cancer: a preliminary report of the functional results of laryngeal irradiation. Int J Radiat Oncol Biol Phys 1990;19:123-7.
26. Haugen H, Johansson KA, Mercke C. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys 2002;52:109-19.
27. Hendry JH, Roberts SA, Slevin NJ, et al. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centers in Manchester, UK, and Toronto, Canada. Radiother Oncol 1994;31:14-22.
28. Hermans R, Feron M, Bellon E, et al. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys 1998;40:553-7.
29. Hirola S, Soejima T, Obayashi K, et al. Radiotherapy of T1 and T2 glottic cancer. Analysis of anterior commissure involvement. Radiat Med 1996;14:297-302.
30. Hirvikoski P, Kumpulaienen E, Virtaniemi J, et al. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 1997;15:3111-20.
31. Hliniak A, Gwiazdowska B, Szutkowski Z, et al. A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a week shortening overall time. Radiother Oncol 2002;62:1-10.
32. Hoyt DJ, Lettinga JW, Leopold KA, et al. The effect of head and neck radiation therapy on voice quality. Laryngoscope 1992;102:477-80.
33. International Commission on Radiation Units and Measurements (ICRU). Prescribing, recording, and reporting photon beam therapy, ICRU Report 50. Bethesda: ICRU Publications' Office, 1993.
34. Johansen LV, Grau C, Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol 2002;63:257-67.
35. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
36. Karim ABMF, Snow GB, Slek HTH, et al. The quality of voice in patients irradiated for laryngeal carcinoma. Cancer 1983;51:47-9.
37. Kurek R, Kalogera-Fountzila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-7.
38. Laccourreye O, Muscatello L, Laccourreye L, et al. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for early glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol 1997;18:385-90.
39. Le Q-TX, Fu K, Kroll S, et al. Influence of fractionation size, total dose, and overall treatment time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;39:115-26.
40. Lusinchi A, Dube P, Wibault P, et al. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother Oncol 1989;15:313-9.
41. Marshak G, Brenner B, Shvero J, et al. Prognostic factors for local control of early glottic cancer: the Rabin medical center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys 1999;43:1009-13.
42. Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19:4029-36.
43. Mendenhall WM, Parsons JT, Stringer SP, et al. Management of Tis, T1, T2 squamous cell carcinoma of the glottic larynx. Am J Otolaryngol 1994;15:250-7.
44. Million RR, Cassissi NJ, Mancuso AA. Larynx carcinoma. In: Million RR, Cassissi NJ, eds. Management of head and neck cancer, 2nd edn. Philadelphia: Lippincott, 1994:431-99.
45. Morgan DAL, Robinson HF, Marsh L, et al. Vocal quality 10 years after radiotherapy for early glottic cancer. Clin Radiol 1988;39:295-6.
46. Morris MR, Canonico D, Blank C. A critical review of radiotherapy in the management of T1 glottic carcinoma. Am J Otolaryngol 1994;15:276-80.
47. Myers EN, Wagner RL, Johnson JT. Microlaryngoscopic surgery for T1 glottic lesions: a cost effective option. Ann Otol Rhinol Laryngol 1994;103:28-30.
48. Narayana A, Vaughan ATM, Kathuria S, et al. p53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 2000;46:21-6.
49. National Institutes of Health. National Cancer Institute Common Toxicity Criteria, version 2.0., Appendix IV. RTOG/EORTC Late Radiation Morbidity Scoring Scheme. Bethesda: National Institutes of Health, 1999:72-3.
50. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: part II. Br J Cancer 1977;35:1-39.
51. Reddy SP, Mohideen N, Marra S, et al. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother Oncol 1997;47:161-6.
52. Roberts SA, Hendry JH. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers. Int J Radiat Oncol Biol Phys 1999;45:1247-57.
53. Roberts SA, Hendry JH, Brewster AE, et al. The influence of radiotherapy treatment time on control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. Br J Radiol 1994;67:790-4.
54. Rube C, Micke O, Grevers G, et al. Primary radiotherapy of laryngeal carcinoma: an analysis of the therapeutic results and of the relapse behavior in 283 patients. Strahlenther Onkol 1997;173:83-90.
55. 2 laser. Eur Arch Otorhinolaryngol 1995;252:146-8.
56. Rudoltz MS, Bonammar A, Mohindolin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1993;26:767-72.
57. Rydell R, Schalen L, Fex S, et al. Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol 1995;115:560-5.
58. Saarilahti K, Kajanti M, Lehtonen H, et al. Repopulation during radical radiotherapy for T1 glottic cancer. Radiother Oncol 1998;47:155-9.
59. Schafer U, Micke O, Muller SB, et al. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol 2003;179:527-34.
60. Shvero J, Hadar T, Segal K, et al. T1 glottic carcinoma involving the anterior commissure. Eur J Surg Oncol 1994;20:557-60.
61. Sombeck MD, Kalbaugh KJ, Mendenhall WM, et al. Radiotherapy for early vocal cord cancer: a dosimetric analysis of Co 60 versus 6 MV photons. Head Neck 1996;18:167-73.
62. Spector JG, Sessions DG, Chao KS, et al. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck 1999;21:116-23.
63. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993;14:116-21.
64. Teshima T, Chatani M, Inoue T. Radiation therapy for early glottic cancer (T1N0M0). II. Prospective randomized study concerning radiation field. Int J Radiat Oncol Biol Phys 1990;18:119-23.
65. Tombolini V, Zurlo A, Cavaceppi P, et al. Radiotherapy for T1 carcinoma of the glottis. Tumori 1995;81:414-8.
66. Turesson I, Sandberg N, Mercke C, et al. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. Acta Oncol 1991;30:357-62.
67. Van den Bogaert M, Van der Leest A, Rijnders A, et al. Does tumor control decrease by prolonging overall treatment time or interruptions of treatment in laryngeal cancer? Radiother Oncol 1995;36:177-82.
68. Wang CC. Radiation therapy of laryngeal tumors: curative radiation therapy. In: Thawley SE, Panje WR, eds. Comprehensive management of head and neck tumors. Philadelphia: Sanders, 1987:906-19.
69. Warde P, O'Sullivan B, Bristow RG, et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998;41:347-53.
70. Yu E, Shenouda G, Beaudet MP, et al. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;37:587-91.
71. Zohar Y, Rahima M, Shvili Y, et al. The controversial treatment of anterior commissure carcinoma of the larynx. Laryngoscope 1992;102:69-72.